spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  SYMBICORT 

 HSMN NewsFeed - 31 Jul 2023
Viatris Announces Launch of Breyna(TM) (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the First FDA-Approved Generic Version of Symbicort(R) for People with Asthma and Chronic Obstructive Pulmonary Disease, in Partnership with Kindeva
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 27 Jan 2020
Ninety Percent of Patients Can't Use Inhalers Correctly, Digital Inhaler CapMedic Receives FDA Clearance to Change That
Devices Drug Delivery FDA
 HSMN NewsFeed - 27 Sep 2016
Insmed Appoints Roger Adsett as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jun 2016
Theravance Biopharma Highlights Positive Top-Line Results From Pivotal Phase 3 FULFIL Study of the Closed Triple Announced by GlaxoSmithKline and Innoviva
Biopharmaceuticals
 HSMN NewsFeed - 13 Aug 2015
Innocoll AG Appoints Rich Fante as Chief Commercial Officer and Head of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 May 2012
SYMBICORT(R) (budesonide/formoterol fumarate dihydrate) Long-Term Study Shows Similar Safety Profile When Compared to Budesonide Monotherapy in African-American Patients with Asthma
Biopharmaceuticals
 HSMN NewsFeed - 21 May 2009
Budesonide/Formoterol Plus Tiotropium Improves the Quality of Life of Patients With Severe COPD
Biopharmaceuticals
 HSMN NewsFeed - 2 Aug 2008
Inhaler Devices are Still a Major Hurdle in Asthma and COPD Treatment
Biopharmaceuticals Devices Drug Delivery
 HSMN NewsFeed - 4 Jun 2008
AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Jun 2007
AstraZeneca Announces SYMBICORT(R) is Now Available in the U.S.
Biopharmaceuticals
 HSMN NewsFeed - 13 Nov 2006
Approved Asthma Therapy SYMBICORT Improves Lung Function Safely and Effectively
Biopharmaceuticals
 HSMN NewsFeed - 13 Nov 2006
Once- or Twice-Daily Treatment With PULMICORT RESPULES(R) (budesonide inhalation suspension) Significantly Increased Percentage of Days Asthma Is Controlled
Biopharmaceuticals
 HSMN NewsFeed - 6 Sep 2006
SkyePharma and Mundipharma Announce Exclusive Licence Agreement for Marketing and Distribution of Flutiform(TM) in Europe
Biopharmaceuticals Licensing
 HSMN NewsFeed - 8 May 2006
Kos and SkyePharma Sign Exclusive License Agreement for the Marketing and Distribution of Flutiform(TM) in the United States
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 8 May 2006
SkyePharma and Kos Announce Exclusive Licence Agreement for Marketing and Distribution of Flutiform(TM) in the United States
Biopharmaceuticals Licensing Distribution
Return to NewsFeed  
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.